Edwards Lifesciences (EW) Valuation Check After Recent Share Price Momentum: Is the Market Already Pricing in Future Growth?

Edwards Lifesciences (EW) stock has gained 2.1% in a day, following a 10.1% rise in the past month and a small decline over the past 3 months. The share price of $83.56 is a 7% discount to one intrinsic value estimate and 15% below some analyst targets. The planned launch of the transcatheter tricuspid valve EVOQUE in 2024 is expected to increase revenues, but tariffs and the canceled JenaValve deal could impact earnings.